nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Bexarotene—hematologic cancer	0.0438	0.0829	CbGbCtD
Tiagabine—CYP3A4—Busulfan—hematologic cancer	0.0407	0.0771	CbGbCtD
Tiagabine—CYP3A4—Lomustine—hematologic cancer	0.0407	0.0771	CbGbCtD
Tiagabine—CYP3A4—Thiotepa—hematologic cancer	0.0363	0.0687	CbGbCtD
Tiagabine—CYP3A4—Methoxsalen—hematologic cancer	0.0282	0.0534	CbGbCtD
Tiagabine—CYP3A4—Bortezomib—hematologic cancer	0.0269	0.0508	CbGbCtD
Tiagabine—CYP3A4—Daunorubicin—hematologic cancer	0.0257	0.0486	CbGbCtD
Tiagabine—CYP3A4—Cytarabine—hematologic cancer	0.0227	0.0429	CbGbCtD
Tiagabine—CYP3A4—Teniposide—hematologic cancer	0.0223	0.0422	CbGbCtD
Tiagabine—CYP3A4—Ifosfamide—hematologic cancer	0.0206	0.039	CbGbCtD
Tiagabine—CYP3A4—Imatinib—hematologic cancer	0.0197	0.0372	CbGbCtD
Tiagabine—CYP3A4—Ruxolitinib—hematologic cancer	0.0185	0.0351	CbGbCtD
Tiagabine—CYP3A4—Nilotinib—hematologic cancer	0.0179	0.0338	CbGbCtD
Tiagabine—CYP3A4—Vinorelbine—hematologic cancer	0.0177	0.0335	CbGbCtD
Tiagabine—CYP3A4—Triamcinolone—hematologic cancer	0.0162	0.0307	CbGbCtD
Tiagabine—CYP3A4—Dasatinib—hematologic cancer	0.0158	0.0299	CbGbCtD
Tiagabine—CYP3A4—Mitoxantrone—hematologic cancer	0.0156	0.0295	CbGbCtD
Tiagabine—CYP3A4—Betamethasone—hematologic cancer	0.0139	0.0263	CbGbCtD
Tiagabine—CYP3A4—Prednisolone—hematologic cancer	0.0137	0.026	CbGbCtD
Tiagabine—CYP3A4—Prednisone—hematologic cancer	0.013	0.0245	CbGbCtD
Tiagabine—CYP3A4—Irinotecan—hematologic cancer	0.0123	0.0233	CbGbCtD
Tiagabine—CYP3A4—Vinblastine—hematologic cancer	0.0109	0.0207	CbGbCtD
Tiagabine—CYP3A4—Vincristine—hematologic cancer	0.0107	0.0203	CbGbCtD
Tiagabine—CYP3A4—Etoposide—hematologic cancer	0.00985	0.0186	CbGbCtD
Tiagabine—CYP3A4—Dexamethasone—hematologic cancer	0.0081	0.0153	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—hematologic cancer	0.00672	0.0127	CbGbCtD
Tiagabine—SLC6A1—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—hematologic cancer	0.00389	0.0863	CbGpPWpGaD
Tiagabine—SLC6A1—Amine compound SLC transporters—SLC22A1—hematologic cancer	0.0027	0.0599	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNFRSF11B—hematologic cancer	0.0025	0.0554	CbGpPWpGaD
Tiagabine—SLC6A1—Neurotransmitter Release Cycle—SLC22A1—hematologic cancer	0.00206	0.0457	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—hematologic cancer	0.00123	0.0272	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TSC2—hematologic cancer	0.00116	0.0258	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—MAPK14—hematologic cancer	0.00111	0.0246	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.00105	0.0234	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—hematologic cancer	0.001	0.0223	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—ABCC3—hematologic cancer	0.000831	0.0185	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TXN—hematologic cancer	0.000831	0.0185	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000813	0.0181	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—UGT1A1—hematologic cancer	0.000782	0.0174	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—hematologic cancer	0.000725	0.0161	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000725	0.0161	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.00071	0.0158	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.000667	0.0148	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC22A1—hematologic cancer	0.000591	0.0131	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000586	0.013	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000545	0.0121	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ADCY7—hematologic cancer	0.000542	0.012	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—NQO1—hematologic cancer	0.000536	0.0119	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TNF—hematologic cancer	0.000526	0.0117	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HSP90AA1—hematologic cancer	0.000504	0.0112	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CAMK2D—hematologic cancer	0.000482	0.0107	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000479	0.0106	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—SLC22A1—hematologic cancer	0.000453	0.0101	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000452	0.01	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—hematologic cancer	0.000447	0.00992	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000444	0.00987	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000436	0.00968	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—UGT1A1—hematologic cancer	0.000427	0.00947	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	0.000418	0.00928	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ADCY7—hematologic cancer	0.000415	0.00922	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000413	0.00918	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—hematologic cancer	0.000411	0.00912	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—HGF—hematologic cancer	0.000411	0.00912	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—hematologic cancer	0.00039	0.00866	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000388	0.00863	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.000388	0.00862	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—ABCG2—hematologic cancer	0.00037	0.00821	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CAMK2D—hematologic cancer	0.000369	0.0082	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000368	0.00818	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000361	0.00802	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—PDGFB—hematologic cancer	0.000353	0.00784	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—UGT1A1—hematologic cancer	0.000349	0.00775	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000337	0.00748	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000337	0.00748	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000337	0.00748	CbGpPWpGaD
Tiagabine—CYP3A4—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.000314	0.00697	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—PRKCG—hematologic cancer	0.000305	0.00677	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000303	0.00673	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000282	0.00627	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	0.000266	0.00591	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	0.000244	0.00541	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—NQO1—hematologic cancer	0.000239	0.00531	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000234	0.0052	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—PRKCG—hematologic cancer	0.000233	0.00518	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	0.00023	0.0051	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—CREB1—hematologic cancer	0.000226	0.00501	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	0.000223	0.00495	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000223	0.00495	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BRAF—hematologic cancer	0.000223	0.00495	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	0.000222	0.00492	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.00022	0.00489	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	0.000217	0.00482	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	0.000198	0.00439	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	0.000193	0.0043	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MDM2—hematologic cancer	0.000187	0.00415	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—hematologic cancer	0.000183	0.00407	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—CREB1—hematologic cancer	0.000173	0.00384	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000172	0.00382	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BRAF—hematologic cancer	0.000171	0.00379	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—TGFB1—hematologic cancer	0.000167	0.00372	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	0.000167	0.0037	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	0.000162	0.00361	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—MDM2—hematologic cancer	0.000143	0.00318	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000142	0.00315	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	0.000135	0.00301	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000119	0.00265	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000113	0.00252	CbGpPWpGaD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000113	0.0025	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	0.000102	0.00227	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	9.46e-05	0.0021	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	9.33e-05	0.00207	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	9.05e-05	0.00201	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ALB—hematologic cancer	8.47e-05	0.00188	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—HRAS—hematologic cancer	7.85e-05	0.00174	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	6.1e-05	0.00135	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	6.01e-05	0.00134	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	5.73e-05	0.00127	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	5.65e-05	0.00126	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	5.06e-05	0.00112	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—MTR—hematologic cancer	4.97e-05	0.0011	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	4.73e-05	0.00105	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	3.28e-05	0.000728	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	3.23e-05	0.000718	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	3.01e-05	0.000669	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.97e-05	0.00066	CbGpPWpGaD
Tiagabine—Decreased appetite—Betamethasone—hematologic cancer	2.93e-05	6.87e-05	CcSEcCtD
Tiagabine—Nausea—Irinotecan—hematologic cancer	2.92e-05	6.86e-05	CcSEcCtD
Tiagabine—Nausea—Mitoxantrone—hematologic cancer	2.92e-05	6.86e-05	CcSEcCtD
Tiagabine—Infection—Prednisone—hematologic cancer	2.92e-05	6.84e-05	CcSEcCtD
Tiagabine—Back pain—Methotrexate—hematologic cancer	2.91e-05	6.82e-05	CcSEcCtD
Tiagabine—Fatigue—Dexamethasone—hematologic cancer	2.9e-05	6.82e-05	CcSEcCtD
Tiagabine—Fatigue—Betamethasone—hematologic cancer	2.9e-05	6.82e-05	CcSEcCtD
Tiagabine—Chills—Epirubicin—hematologic cancer	2.9e-05	6.8e-05	CcSEcCtD
Tiagabine—Pruritus—Etoposide—hematologic cancer	2.9e-05	6.8e-05	CcSEcCtD
Tiagabine—Shock—Prednisone—hematologic cancer	2.89e-05	6.77e-05	CcSEcCtD
Tiagabine—Pain—Betamethasone—hematologic cancer	2.88e-05	6.76e-05	CcSEcCtD
Tiagabine—Pain—Dexamethasone—hematologic cancer	2.88e-05	6.76e-05	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—hematologic cancer	2.88e-05	6.76e-05	CcSEcCtD
Tiagabine—Tachycardia—Prednisone—hematologic cancer	2.86e-05	6.72e-05	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—hematologic cancer	2.85e-05	6.7e-05	CcSEcCtD
Tiagabine—Nausea—Gemcitabine—hematologic cancer	2.85e-05	6.68e-05	CcSEcCtD
Tiagabine—Vomiting—Cisplatin—hematologic cancer	2.84e-05	6.67e-05	CcSEcCtD
Tiagabine—Hyperhidrosis—Prednisone—hematologic cancer	2.84e-05	6.65e-05	CcSEcCtD
Tiagabine—Rash—Cisplatin—hematologic cancer	2.82e-05	6.61e-05	CcSEcCtD
Tiagabine—Dermatitis—Cisplatin—hematologic cancer	2.82e-05	6.6e-05	CcSEcCtD
Tiagabine—Diarrhoea—Etoposide—hematologic cancer	2.8e-05	6.57e-05	CcSEcCtD
Tiagabine—Anorexia—Prednisone—hematologic cancer	2.8e-05	6.56e-05	CcSEcCtD
Tiagabine—Ill-defined disorder—Methotrexate—hematologic cancer	2.79e-05	6.54e-05	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—hematologic cancer	2.79e-05	6.54e-05	CcSEcCtD
Tiagabine—Anaemia—Methotrexate—hematologic cancer	2.78e-05	6.52e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Dexamethasone—hematologic cancer	2.78e-05	6.51e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Betamethasone—hematologic cancer	2.78e-05	6.51e-05	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—hematologic cancer	2.77e-05	6.5e-05	CcSEcCtD
Tiagabine—Tension—Epirubicin—hematologic cancer	2.76e-05	6.47e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.76e-05	6.46e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.76e-05	6.46e-05	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—hematologic cancer	2.75e-05	6.46e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Triamcinolone—hematologic cancer	2.74e-05	6.42e-05	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—hematologic cancer	2.73e-05	6.41e-05	CcSEcCtD
Tiagabine—Back pain—Epirubicin—hematologic cancer	2.72e-05	6.38e-05	CcSEcCtD
Tiagabine—Malaise—Methotrexate—hematologic cancer	2.71e-05	6.36e-05	CcSEcCtD
Tiagabine—Dizziness—Etoposide—hematologic cancer	2.71e-05	6.35e-05	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—hematologic cancer	2.7e-05	6.34e-05	CcSEcCtD
Tiagabine—Vertigo—Methotrexate—hematologic cancer	2.7e-05	6.33e-05	CcSEcCtD
Tiagabine—Leukopenia—Methotrexate—hematologic cancer	2.69e-05	6.31e-05	CcSEcCtD
Tiagabine—Chills—Doxorubicin—hematologic cancer	2.68e-05	6.29e-05	CcSEcCtD
Tiagabine—Urticaria—Betamethasone—hematologic cancer	2.68e-05	6.28e-05	CcSEcCtD
Tiagabine—Urticaria—Dexamethasone—hematologic cancer	2.68e-05	6.28e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.67e-05	6.27e-05	CcSEcCtD
Tiagabine—Dizziness—Prednisolone—hematologic cancer	2.67e-05	6.26e-05	CcSEcCtD
Tiagabine—Asthenia—Triamcinolone—hematologic cancer	2.66e-05	6.25e-05	CcSEcCtD
Tiagabine—Abdominal pain—Dexamethasone—hematologic cancer	2.66e-05	6.25e-05	CcSEcCtD
Tiagabine—Abdominal pain—Betamethasone—hematologic cancer	2.66e-05	6.25e-05	CcSEcCtD
Tiagabine—Body temperature increased—Betamethasone—hematologic cancer	2.66e-05	6.25e-05	CcSEcCtD
Tiagabine—Body temperature increased—Dexamethasone—hematologic cancer	2.66e-05	6.25e-05	CcSEcCtD
Tiagabine—Nausea—Cisplatin—hematologic cancer	2.65e-05	6.23e-05	CcSEcCtD
Tiagabine—Insomnia—Prednisone—hematologic cancer	2.65e-05	6.23e-05	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—hematologic cancer	2.64e-05	6.2e-05	CcSEcCtD
Tiagabine—Paraesthesia—Prednisone—hematologic cancer	2.63e-05	6.18e-05	CcSEcCtD
Tiagabine—Pruritus—Triamcinolone—hematologic cancer	2.63e-05	6.16e-05	CcSEcCtD
Tiagabine—Cough—Methotrexate—hematologic cancer	2.62e-05	6.15e-05	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—hematologic cancer	2.61e-05	6.12e-05	CcSEcCtD
Tiagabine—Vomiting—Etoposide—hematologic cancer	2.6e-05	6.11e-05	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—hematologic cancer	2.6e-05	6.1e-05	CcSEcCtD
Tiagabine—Agitation—Epirubicin—hematologic cancer	2.58e-05	6.06e-05	CcSEcCtD
Tiagabine—Dyspepsia—Prednisone—hematologic cancer	2.58e-05	6.06e-05	CcSEcCtD
Tiagabine—Rash—Etoposide—hematologic cancer	2.58e-05	6.06e-05	CcSEcCtD
Tiagabine—Dermatitis—Etoposide—hematologic cancer	2.58e-05	6.05e-05	CcSEcCtD
Tiagabine—Headache—Etoposide—hematologic cancer	2.56e-05	6.02e-05	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—hematologic cancer	2.56e-05	6.01e-05	CcSEcCtD
Tiagabine—Arthralgia—Methotrexate—hematologic cancer	2.56e-05	6e-05	CcSEcCtD
Tiagabine—Chest pain—Methotrexate—hematologic cancer	2.56e-05	6e-05	CcSEcCtD
Tiagabine—Myalgia—Methotrexate—hematologic cancer	2.56e-05	6e-05	CcSEcCtD
Tiagabine—Tension—Doxorubicin—hematologic cancer	2.55e-05	5.99e-05	CcSEcCtD
Tiagabine—Decreased appetite—Prednisone—hematologic cancer	2.55e-05	5.98e-05	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—hematologic cancer	2.55e-05	5.98e-05	CcSEcCtD
Tiagabine—Rash—Prednisolone—hematologic cancer	2.55e-05	5.97e-05	CcSEcCtD
Tiagabine—Dermatitis—Prednisolone—hematologic cancer	2.54e-05	5.97e-05	CcSEcCtD
Tiagabine—Malaise—Epirubicin—hematologic cancer	2.54e-05	5.95e-05	CcSEcCtD
Tiagabine—Fatigue—Prednisone—hematologic cancer	2.53e-05	5.94e-05	CcSEcCtD
Tiagabine—Headache—Prednisolone—hematologic cancer	2.53e-05	5.93e-05	CcSEcCtD
Tiagabine—Discomfort—Methotrexate—hematologic cancer	2.53e-05	5.93e-05	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—hematologic cancer	2.53e-05	5.93e-05	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—hematologic cancer	2.53e-05	5.93e-05	CcSEcCtD
Tiagabine—Syncope—Epirubicin—hematologic cancer	2.52e-05	5.92e-05	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—hematologic cancer	2.52e-05	5.91e-05	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—hematologic cancer	2.52e-05	5.9e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—GMPS—hematologic cancer	2.51e-05	0.000558	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FTCD—hematologic cancer	2.51e-05	0.000558	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PHYH—hematologic cancer	2.51e-05	0.000558	CbGpPWpGaD
Tiagabine—Constipation—Prednisone—hematologic cancer	2.51e-05	5.89e-05	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—hematologic cancer	2.5e-05	5.87e-05	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—hematologic cancer	2.48e-05	5.83e-05	CcSEcCtD
Tiagabine—Confusional state—Methotrexate—hematologic cancer	2.47e-05	5.8e-05	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—hematologic cancer	2.47e-05	5.8e-05	CcSEcCtD
Tiagabine—Dizziness—Triamcinolone—hematologic cancer	2.46e-05	5.76e-05	CcSEcCtD
Tiagabine—Cough—Epirubicin—hematologic cancer	2.45e-05	5.76e-05	CcSEcCtD
Tiagabine—Infection—Methotrexate—hematologic cancer	2.44e-05	5.72e-05	CcSEcCtD
Tiagabine—Nausea—Etoposide—hematologic cancer	2.43e-05	5.71e-05	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—hematologic cancer	2.43e-05	5.7e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Prednisone—hematologic cancer	2.42e-05	5.67e-05	CcSEcCtD
Tiagabine—Asthenia—Dexamethasone—hematologic cancer	2.42e-05	5.67e-05	CcSEcCtD
Tiagabine—Asthenia—Betamethasone—hematologic cancer	2.42e-05	5.67e-05	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.41e-05	5.66e-05	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—hematologic cancer	2.4e-05	5.64e-05	CcSEcCtD
Tiagabine—Thrombocytopenia—Methotrexate—hematologic cancer	2.4e-05	5.63e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Prednisone—hematologic cancer	2.4e-05	5.63e-05	CcSEcCtD
Tiagabine—Nausea—Prednisolone—hematologic cancer	2.4e-05	5.63e-05	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—hematologic cancer	2.39e-05	5.62e-05	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—hematologic cancer	2.39e-05	5.62e-05	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—hematologic cancer	2.39e-05	5.62e-05	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—hematologic cancer	2.39e-05	5.61e-05	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—hematologic cancer	2.39e-05	5.6e-05	CcSEcCtD
Tiagabine—Pruritus—Dexamethasone—hematologic cancer	2.38e-05	5.59e-05	CcSEcCtD
Tiagabine—Pruritus—Betamethasone—hematologic cancer	2.38e-05	5.59e-05	CcSEcCtD
Tiagabine—Hyperhidrosis—Methotrexate—hematologic cancer	2.37e-05	5.56e-05	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—hematologic cancer	2.37e-05	5.55e-05	CcSEcCtD
Tiagabine—Vomiting—Triamcinolone—hematologic cancer	2.36e-05	5.54e-05	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—hematologic cancer	2.35e-05	5.5e-05	CcSEcCtD
Tiagabine—Rash—Triamcinolone—hematologic cancer	2.34e-05	5.49e-05	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—hematologic cancer	2.34e-05	5.49e-05	CcSEcCtD
Tiagabine—Dermatitis—Triamcinolone—hematologic cancer	2.34e-05	5.49e-05	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—hematologic cancer	2.34e-05	5.48e-05	CcSEcCtD
Tiagabine—Anorexia—Methotrexate—hematologic cancer	2.34e-05	5.48e-05	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—hematologic cancer	2.33e-05	5.47e-05	CcSEcCtD
Tiagabine—Urticaria—Prednisone—hematologic cancer	2.33e-05	5.47e-05	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—hematologic cancer	2.33e-05	5.46e-05	CcSEcCtD
Tiagabine—Headache—Triamcinolone—hematologic cancer	2.33e-05	5.46e-05	CcSEcCtD
Tiagabine—Body temperature increased—Prednisone—hematologic cancer	2.32e-05	5.44e-05	CcSEcCtD
Tiagabine—Abdominal pain—Prednisone—hematologic cancer	2.32e-05	5.44e-05	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—hematologic cancer	2.31e-05	5.43e-05	CcSEcCtD
Tiagabine—Diarrhoea—Dexamethasone—hematologic cancer	2.31e-05	5.41e-05	CcSEcCtD
Tiagabine—Diarrhoea—Betamethasone—hematologic cancer	2.31e-05	5.41e-05	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—hematologic cancer	2.3e-05	5.39e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.3e-05	0.00051	CbGpPWpGaD
Tiagabine—Oedema—Epirubicin—hematologic cancer	2.29e-05	5.38e-05	CcSEcCtD
Tiagabine—Hypotension—Methotrexate—hematologic cancer	2.29e-05	5.38e-05	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—hematologic cancer	2.29e-05	5.36e-05	CcSEcCtD
Tiagabine—Infection—Epirubicin—hematologic cancer	2.28e-05	5.35e-05	CcSEcCtD
Tiagabine—Cough—Doxorubicin—hematologic cancer	2.27e-05	5.33e-05	CcSEcCtD
Tiagabine—Shock—Epirubicin—hematologic cancer	2.26e-05	5.3e-05	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—hematologic cancer	2.25e-05	5.27e-05	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—hematologic cancer	2.25e-05	5.27e-05	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—hematologic cancer	2.24e-05	5.25e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.23e-05	5.24e-05	CcSEcCtD
Tiagabine—Dizziness—Betamethasone—hematologic cancer	2.23e-05	5.23e-05	CcSEcCtD
Tiagabine—Dizziness—Dexamethasone—hematologic cancer	2.23e-05	5.23e-05	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—hematologic cancer	2.22e-05	5.2e-05	CcSEcCtD
Tiagabine—Insomnia—Methotrexate—hematologic cancer	2.22e-05	5.2e-05	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—hematologic cancer	2.22e-05	5.2e-05	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—hematologic cancer	2.22e-05	5.2e-05	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—hematologic cancer	2.22e-05	5.2e-05	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—hematologic cancer	2.21e-05	5.18e-05	CcSEcCtD
Tiagabine—Nausea—Triamcinolone—hematologic cancer	2.21e-05	5.17e-05	CcSEcCtD
Tiagabine—Paraesthesia—Methotrexate—hematologic cancer	2.2e-05	5.17e-05	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—hematologic cancer	2.19e-05	5.13e-05	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—hematologic cancer	2.19e-05	5.13e-05	CcSEcCtD
Tiagabine—Dyspnoea—Methotrexate—hematologic cancer	2.19e-05	5.13e-05	CcSEcCtD
Tiagabine—Somnolence—Methotrexate—hematologic cancer	2.18e-05	5.11e-05	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—hematologic cancer	2.17e-05	5.08e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Prednisone—hematologic cancer	2.16e-05	5.07e-05	CcSEcCtD
Tiagabine—Dyspepsia—Methotrexate—hematologic cancer	2.16e-05	5.06e-05	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—hematologic cancer	2.14e-05	5.03e-05	CcSEcCtD
Tiagabine—Vomiting—Betamethasone—hematologic cancer	2.14e-05	5.03e-05	CcSEcCtD
Tiagabine—Vomiting—Dexamethasone—hematologic cancer	2.14e-05	5.03e-05	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—hematologic cancer	2.14e-05	5.02e-05	CcSEcCtD
Tiagabine—Decreased appetite—Methotrexate—hematologic cancer	2.13e-05	5e-05	CcSEcCtD
Tiagabine—Rash—Dexamethasone—hematologic cancer	2.12e-05	4.98e-05	CcSEcCtD
Tiagabine—Rash—Betamethasone—hematologic cancer	2.12e-05	4.98e-05	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—hematologic cancer	2.12e-05	4.98e-05	CcSEcCtD
Tiagabine—Dermatitis—Dexamethasone—hematologic cancer	2.12e-05	4.98e-05	CcSEcCtD
Tiagabine—Dermatitis—Betamethasone—hematologic cancer	2.12e-05	4.98e-05	CcSEcCtD
Tiagabine—Fatigue—Methotrexate—hematologic cancer	2.11e-05	4.96e-05	CcSEcCtD
Tiagabine—Headache—Betamethasone—hematologic cancer	2.11e-05	4.95e-05	CcSEcCtD
Tiagabine—Headache—Dexamethasone—hematologic cancer	2.11e-05	4.95e-05	CcSEcCtD
Tiagabine—Infection—Doxorubicin—hematologic cancer	2.11e-05	4.95e-05	CcSEcCtD
Tiagabine—Asthenia—Prednisone—hematologic cancer	2.11e-05	4.94e-05	CcSEcCtD
Tiagabine—Pain—Methotrexate—hematologic cancer	2.1e-05	4.92e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.09e-05	4.91e-05	CcSEcCtD
Tiagabine—Shock—Doxorubicin—hematologic cancer	2.09e-05	4.9e-05	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.08e-05	4.88e-05	CcSEcCtD
Tiagabine—Pruritus—Prednisone—hematologic cancer	2.08e-05	4.87e-05	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—hematologic cancer	2.08e-05	4.87e-05	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—hematologic cancer	2.07e-05	4.86e-05	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—hematologic cancer	2.06e-05	4.83e-05	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.05e-05	4.82e-05	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—hematologic cancer	2.05e-05	4.8e-05	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—hematologic cancer	2.04e-05	4.79e-05	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—hematologic cancer	2.02e-05	4.75e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Methotrexate—hematologic cancer	2.02e-05	4.74e-05	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—hematologic cancer	2.02e-05	4.74e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.01e-05	0.000446	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ASNS—hematologic cancer	2.01e-05	0.000446	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—DCK—hematologic cancer	2.01e-05	0.000446	CbGpPWpGaD
Tiagabine—Diarrhoea—Prednisone—hematologic cancer	2.01e-05	4.71e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.01e-05	4.7e-05	CcSEcCtD
Tiagabine—Nausea—Dexamethasone—hematologic cancer	2e-05	4.7e-05	CcSEcCtD
Tiagabine—Nausea—Betamethasone—hematologic cancer	2e-05	4.7e-05	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—hematologic cancer	1.99e-05	4.68e-05	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—hematologic cancer	1.98e-05	4.66e-05	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—hematologic cancer	1.98e-05	4.64e-05	CcSEcCtD
Tiagabine—Constipation—Epirubicin—hematologic cancer	1.96e-05	4.6e-05	CcSEcCtD
Tiagabine—Pain—Epirubicin—hematologic cancer	1.96e-05	4.6e-05	CcSEcCtD
Tiagabine—Urticaria—Methotrexate—hematologic cancer	1.95e-05	4.57e-05	CcSEcCtD
Tiagabine—Dizziness—Prednisone—hematologic cancer	1.94e-05	4.55e-05	CcSEcCtD
Tiagabine—Body temperature increased—Methotrexate—hematologic cancer	1.94e-05	4.55e-05	CcSEcCtD
Tiagabine—Abdominal pain—Methotrexate—hematologic cancer	1.94e-05	4.55e-05	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.93e-05	4.54e-05	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—hematologic cancer	1.92e-05	4.51e-05	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—hematologic cancer	1.91e-05	4.47e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—HDC—hematologic cancer	1.9e-05	0.000423	CbGpPWpGaD
Tiagabine—Dyspnoea—Doxorubicin—hematologic cancer	1.89e-05	4.44e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—hematologic cancer	1.89e-05	4.44e-05	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—hematologic cancer	1.89e-05	4.43e-05	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.88e-05	4.4e-05	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—hematologic cancer	1.87e-05	4.39e-05	CcSEcCtD
Tiagabine—Vomiting—Prednisone—hematologic cancer	1.87e-05	4.38e-05	CcSEcCtD
Tiagabine—Rash—Prednisone—hematologic cancer	1.85e-05	4.34e-05	CcSEcCtD
Tiagabine—Dermatitis—Prednisone—hematologic cancer	1.85e-05	4.34e-05	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—hematologic cancer	1.85e-05	4.33e-05	CcSEcCtD
Tiagabine—Headache—Prednisone—hematologic cancer	1.84e-05	4.31e-05	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—hematologic cancer	1.83e-05	4.29e-05	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—hematologic cancer	1.82e-05	4.28e-05	CcSEcCtD
Tiagabine—Pain—Doxorubicin—hematologic cancer	1.82e-05	4.26e-05	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—hematologic cancer	1.82e-05	4.26e-05	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—hematologic cancer	1.81e-05	4.26e-05	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—hematologic cancer	1.81e-05	4.26e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Methotrexate—hematologic cancer	1.81e-05	4.24e-05	CcSEcCtD
Tiagabine—Asthenia—Methotrexate—hematologic cancer	1.76e-05	4.13e-05	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—hematologic cancer	1.75e-05	4.11e-05	CcSEcCtD
Tiagabine—Nausea—Prednisone—hematologic cancer	1.74e-05	4.09e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—CDA—hematologic cancer	1.74e-05	0.000387	CbGpPWpGaD
Tiagabine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.74e-05	4.07e-05	CcSEcCtD
Tiagabine—Pruritus—Methotrexate—hematologic cancer	1.73e-05	4.07e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—hematologic cancer	1.69e-05	3.97e-05	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—hematologic cancer	1.69e-05	3.96e-05	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—hematologic cancer	1.68e-05	3.94e-05	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—hematologic cancer	1.68e-05	3.94e-05	CcSEcCtD
Tiagabine—Diarrhoea—Methotrexate—hematologic cancer	1.68e-05	3.94e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—PC—hematologic cancer	1.68e-05	0.000372	CbGpPWpGaD
Tiagabine—Asthenia—Epirubicin—hematologic cancer	1.65e-05	3.86e-05	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—hematologic cancer	1.62e-05	3.81e-05	CcSEcCtD
Tiagabine—Dizziness—Methotrexate—hematologic cancer	1.62e-05	3.8e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—GBA—hematologic cancer	1.62e-05	0.000359	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.62e-05	0.000359	CbGpPWpGaD
Tiagabine—Diarrhoea—Epirubicin—hematologic cancer	1.57e-05	3.68e-05	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—hematologic cancer	1.56e-05	3.67e-05	CcSEcCtD
Tiagabine—Vomiting—Methotrexate—hematologic cancer	1.56e-05	3.66e-05	CcSEcCtD
Tiagabine—Rash—Methotrexate—hematologic cancer	1.55e-05	3.63e-05	CcSEcCtD
Tiagabine—Dermatitis—Methotrexate—hematologic cancer	1.54e-05	3.62e-05	CcSEcCtD
Tiagabine—Headache—Methotrexate—hematologic cancer	1.54e-05	3.6e-05	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—hematologic cancer	1.52e-05	3.57e-05	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—hematologic cancer	1.52e-05	3.56e-05	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—hematologic cancer	1.5e-05	3.52e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—MTAP—hematologic cancer	1.48e-05	0.000329	CbGpPWpGaD
Tiagabine—Vomiting—Epirubicin—hematologic cancer	1.46e-05	3.42e-05	CcSEcCtD
Tiagabine—Nausea—Methotrexate—hematologic cancer	1.46e-05	3.42e-05	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—hematologic cancer	1.45e-05	3.41e-05	CcSEcCtD
Tiagabine—Rash—Epirubicin—hematologic cancer	1.45e-05	3.39e-05	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—hematologic cancer	1.45e-05	3.39e-05	CcSEcCtD
Tiagabine—Headache—Epirubicin—hematologic cancer	1.44e-05	3.37e-05	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—hematologic cancer	1.4e-05	3.29e-05	CcSEcCtD
Tiagabine—Nausea—Epirubicin—hematologic cancer	1.36e-05	3.2e-05	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—hematologic cancer	1.35e-05	3.17e-05	CcSEcCtD
Tiagabine—Rash—Doxorubicin—hematologic cancer	1.34e-05	3.14e-05	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—hematologic cancer	1.34e-05	3.14e-05	CcSEcCtD
Tiagabine—Headache—Doxorubicin—hematologic cancer	1.33e-05	3.12e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—FHL2—hematologic cancer	1.32e-05	0.000293	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AGRN—hematologic cancer	1.29e-05	0.000287	CbGpPWpGaD
Tiagabine—Nausea—Doxorubicin—hematologic cancer	1.26e-05	2.96e-05	CcSEcCtD
Tiagabine—CYP3A4—Metabolism—IDH2—hematologic cancer	1.23e-05	0.000272	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HMMR—hematologic cancer	1.23e-05	0.000272	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.15e-05	0.000256	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA9—hematologic cancer	1.12e-05	0.000249	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACP5—hematologic cancer	1.12e-05	0.000249	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.11e-05	0.000246	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—IDH1—hematologic cancer	1.05e-05	0.000234	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.04e-05	0.000232	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—TXN—hematologic cancer	1.04e-05	0.000232	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.04e-05	0.000232	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.02e-05	0.000227	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	9.8e-06	0.000218	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CRABP1—hematologic cancer	9.54e-06	0.000212	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	9.54e-06	0.000212	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALOX5—hematologic cancer	9.29e-06	0.000206	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NUP98—hematologic cancer	9e-06	0.0002	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ADCY7—hematologic cancer	8.74e-06	0.000194	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOA3—hematologic cancer	8.74e-06	0.000194	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NUP214—hematologic cancer	8.68e-06	0.000193	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCG2—hematologic cancer	8.5e-06	0.000189	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTR—hematologic cancer	8.5e-06	0.000189	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ENO2—hematologic cancer	8.34e-06	0.000185	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—hematologic cancer	8.09e-06	0.00018	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SDC1—hematologic cancer	7.9e-06	0.000176	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NQO1—hematologic cancer	6.72e-06	0.000149	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CD44—hematologic cancer	6.72e-06	0.000149	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYCS—hematologic cancer	6.36e-06	0.000141	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	6.32e-06	0.00014	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—hematologic cancer	5.6e-06	0.000124	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCB1—hematologic cancer	5.31e-06	0.000118	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.15e-06	0.000114	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.15e-06	0.000114	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—MTHFR—hematologic cancer	4.55e-06	0.000101	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.82e-06	8.49e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CREBBP—hematologic cancer	3.55e-06	7.87e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.36e-06	7.47e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALB—hematologic cancer	3.32e-06	7.37e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.17e-06	7.05e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.93e-06	6.51e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTEN—hematologic cancer	2.53e-06	5.62e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—EP300—hematologic cancer	2.41e-06	5.36e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.79e-06	3.97e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.46e-06	3.24e-05	CbGpPWpGaD
